Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) EBIT Margin (2018)

Historic EBIT Margin for DiaMedica Therapeutics (DMAC) over the last 1 years, with Q3 2018 value amounting to 297.4%.

  • DiaMedica Therapeutics' EBIT Margin changed N/A to 297.4% in Q3 2018 from the same period last year, while for Jun 2019 it was 1953.2%, marking a year-over-year change of. This contributed to the annual value of 78473.53% for FY2024, which is 181946500.0% down from last year.
  • Per DiaMedica Therapeutics' latest filing, its EBIT Margin stood at 297.4% for Q3 2018.
  • In the past 5 years, DiaMedica Therapeutics' EBIT Margin registered a high of 297.4% during Q3 2018, and its lowest value of 297.4% during Q3 2018.